Valneva SE (VALN) Net Cash Flow (2021 - 2026)

Valneva SE's (VALN) quarterly Net Cash Flow came in at -$43317.6 in Q1 2026, up 99.53% year-on-year from -$21710.2 in Q1 2025, and up 99.85% quarter-over-quarter from -$28.7 million in Q4 2025.

Valneva SE (VALN) Net Cash Flow (2021 - 2026) Analysis & Trends

Valneva SE has disclosed Net Cash Flow across 6 years of filings, most recently posting -$43317.6 for Q1 2026.

  • Net Cash Flow for Q1 2026 came in at -$43317.6, up 99.53% year-over-year; the trailing twelve-month figure through Mar 2026 was -$50.9 million (down 115.26% YoY), and the FY2025 annual result was -$61.7 million, down 243.03% from the prior year.
  • Net Cash Flow came in at -$43317.6 for Q1 2026 at Valneva SE, up from -$28.7 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $88.6 billion in Q3 2023 to a low of -$88.8 billion in Q2 2023.
  • The 5-year median for Net Cash Flow is -$9.1 million (2025), against an average of $4.5 million.
  • Peak annual rise in Net Cash Flow reached 111539.33% in 2023, while the deepest fall reached 333905.54% in 2023.
  • Valneva SE's Net Cash Flow stood at $30.8 million in 2022, then plunged by 254.04% to -$47.4 million in 2023, then soared by 118.19% to $8.6 million in 2024, then tumbled by 432.74% to -$28.7 million in 2025, then surged by 99.85% to -$43317.6 in 2026.
  • The last three Net Cash Flow figures came in at -$43317.6 (Q1 2026), -$28.7 million (Q4 2025), and -$18.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 2.44 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 625.70 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -2.44 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 457.40 Mn
9 Abivax 94.26 Bn 94.26 Bn - 664,983.53
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn -43,317.59

Historic Data

Download Data
DateValue
Mar 31, 2026 -43,317.59
Mar 31, 2026 -43,317.59
Dec 31, 2025 -28.68 Mn
Dec 31, 2025 -28.68 Mn
Sep 30, 2025 -18.41 Mn
Sep 30, 2025 -18.41 Mn
Jun 30, 2025 -3.75 Mn
Jun 30, 2025 -3.75 Mn
Mar 31, 2025 -9.15 Mn
Mar 31, 2025 -9.15 Mn
Dec 31, 2024 8.62 Mn
Dec 31, 2024 8.62 Mn
Sep 30, 2024 18.23 Bn
Sep 30, 2024 18.23 Bn
Jun 30, 2024 -17.90 Bn
Jun 30, 2024 -17.90 Bn
Mar 31, 2024 55.35 Mn
Mar 31, 2024 55.35 Mn
Dec 31, 2023 -47.39 Mn
Dec 31, 2023 -47.39 Mn